Vytorin vs. Livalo
See how Vytorin and Livalo compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Vytorin combines two cholesterol-lowering drugs in one tablet, while Livalo relies on statin action alone.
Both are taken once daily, but Vytorin typically costs $600 to $650 a month versus $315 to $410 for Livalo without insurance.
Vytorin has trial evidence for reducing heart attacks and strokes after a cardiac event, while Livalo has fewer drug interactions due to minimal liver enzyme metabolism.
Vytorin vs. Livalo Drug Summary
Vytorin
Vytorin combines ezetimibe, a cholesterol absorption inhibitor, with simvastatin, a statin, in a single tablet. It's taken once daily to lower LDL cholesterol, total cholesterol, triglycerides, and Apo B, and to raise HDL, in adults with high cholesterol or certain inherited cholesterol disorders.
Livalo
Livalo (pitavastatin) is a statin that blocks cholesterol production in the liver. It's taken once daily to lower LDL cholesterol, total cholesterol, and triglycerides in adults with high cholesterol or mixed dyslipidemia, and is also approved for children 8 and older with an inherited cholesterol disorder.
Vytorin vs. Livalo Side Effects
Vytorin
Livalo
Vytorin vs. Livalo Dosage
Vytorin
Livalo
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg/10 mg once daily | At the start |
| Maximum dose | 10 mg/80 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 4 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Vytorin
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg/10 mg once daily | At the start |
| Maximum dose | 10 mg/80 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Livalo
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 4 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Vytorin vs. Livalo Indications
Vytorin
Vytorin is FDA-approved to lower LDL cholesterol, total cholesterol, triglycerides, and Apo B, and to raise HDL, in adults with primary hyperlipidemia. It's also approved for two rare inherited conditions, homozygous familial hypercholesterolemia and homozygous sitosterolemia, that respond poorly to statins alone.
Primary hyperlipidemia (LDL, total cholesterol, triglycerides, Apo B)
Raising HDL cholesterol
Homozygous familial hypercholesterolemia
Homozygous sitosterolemia
Livalo
Livalo is FDA-approved to lower LDL cholesterol, total cholesterol, and triglycerides in adults with primary hyperlipidemia or mixed dyslipidemia. It's also approved for heterozygous familial hypercholesterolemia in adults and children 8 and older, and is sometimes used off-label for primary prevention of cardiovascular disease.
Primary hyperlipidemia or mixed dyslipidemia
Heterozygous familial hypercholesterolemia (adults)
Heterozygous familial hypercholesterolemia (children 8+)
Off-label: primary prevention of ASCVD
Vytorin vs. Livalo Pros and Cons
Vytorin
Vytorin pairs a statin with a cholesterol absorption inhibitor, giving it two mechanisms to lower LDL in a single tablet. It carries a higher risk of muscle-related side effects at its top dose and more potential drug interactions than single-agent statins. Its list price is also notably higher than lower-dose statin-only options.
Pros
Two cholesterol-lowering mechanisms in one tablet
Trial evidence for reduced cardiovascular events after a heart attack (IMPROVE-IT)
Approved for rare conditions like homozygous FH and sitosterolemia
Cons
Higher myopathy and rhabdomyolysis risk at the 80 mg dose
More drug interactions through the CYP3A4 pathway
Roughly $600 to $650 per month without insurance, well above Livalo's price
Livalo
Livalo is a single-mechanism statin with minimal liver enzyme interactions, making it a lower-interaction option for patients on multiple medications. It doesn't include a second cholesterol-blocking ingredient, so its LDL reduction may be less pronounced than combination therapy. Its lower price and pediatric approval are notable advantages.
Pros
Minimal CYP3A4 metabolism means fewer drug interactions
Approved for children as young as 8 with familial hypercholesterolemia
Roughly $315 to $410 per month without insurance, lower than Vytorin
Cons
Relies on one mechanism, so LDL lowering may be more modest
Not FDA-approved for homozygous FH or sitosterolemia
Contraindicated with cyclosporine due to increased drug exposure
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.